In a new perspective penned for Science and Diplomacy, NTI | bio’s Margaret Hamburg, Jaime Yassif, Hayley Severance and former NTI David A. Hamburg Distinguished Fellow R. Alta Charo highlight the increasing risks of accidental or deliberate misuse of modern bioscience and biotechnology, and propose the establishment of a new organization.
NTI | bio Interim Vice President and Chair of the NTI | bio Advisory Group Dr. Margaret A. Hamburg is the recipient of the 2022 Philip Hauge Abelson Prize for her distinguished career addressing challenges at the intersection of science, medicine and the public.
The Euro-Atlantic Security Leadership Group (EASLG) supports the Joint Statement of the Leaders of the Five Nuclear-Weapon States Affirming: “A Nuclear War Cannot be Won and Must Never be Fought”
Ernest J. Moniz and Sam Nunn welcome the Joint Statement from the leaders of China, France, Russia, the United Kingdom, and the United States committing to Preventing Nuclear War and Avoiding Arms Races, particularly applauding their affirmation that “a nuclear war cannot be won and must never be fought.”
Thirty years after the creation of the Cooperative Threat Reduction program to address the potentially catastrophic implications of the collapse of the Soviet Union, NTI Co-Chair Sam Nunn and Vice President Laura S.H. Holgate call for a new paradigm to address today’s nuclear security challenges in a paper, Cooperative Risk Management and Reduction: A New Framework for Nuclear Materials Security.
NTI | bio Senior Fellow Jaime Yassif, Ph.D., called on government leaders to take urgent steps to prevent future catastrophic biological events during a Dec. 8, 2021 hearing.
The International Partnership for Nuclear Disarmament Verification (IPNDV) brought together more than 50 representatives from 11 partner countries for a virtual IPNDV 2021 End-of-Year event marking the mid-point of the partnership’s third phase of work.
Report calls on national and global leaders to sustain and expand upon preparedness capacities developed to fight COVID-19
